ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis.

Silvia Susin-Calle et al.PubMed ↗Publisher ↗

No numbers read from the abstract.